Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Initial Q3 Results Are Better-Than-Expected

Published 10/14/2019, 10:43 PM
Updated 07/09/2023, 06:31 AM

As we await news reports from companies reporting Q3 results this morning, we see the October Empire State Index — which had been expected out this morning — was released in error yesterday, with a headline of 4.0. This is better than the 2.0 expected, and between recent highs (+24.3 in August 2018) and lows (-8.6 in June 2019).

Clearly, these results tend toward the more volatile, although interestingly, the estimates for this New York state production survey are almost always higher than the actual — though not for this month. This index looks to be bouncing off those recent lows; the end of the year will be key for this metric.

JPMorgan Chase (JPM), a Zacks Rank #3 (Hold) company, outperformed expectations on both top and bottom lines: $2.68 per share versus $2.44 expected. Revenues came in at $29.3 billion, above the $28.4 billion analysts were looking for. Fixed Income, working off a relatively weak year-over-year comp, was up 25% in Q3 2019, while Credit Loss Provisions rose 60% from the year-ago quarter.

Shares at this hour in the pre-market are up 1.9% on the news, and +7% year to date. JPMorgan has only come up short of earnings estimates once since Q1 2016. For more on JPM’s earnings, click here.

Johnson & Johnson (NYSE:JNJ) (JNJ), a Zacks Rank #4 (Sell)-rated stock ahead of its earnings report, beat estimates on both top and bottom lines this morning: $2.12 per share amounted to a 12-cent positive surprise, on sales of $20.73 billion which surpassed the $20.08 billion expected. Sales in its important Pharma space rose 5.1%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

J&J raised earnings guidance for full-year 2019 — up 9 cents on the bottom end of the range and +4 cents on the top, to $8.67 per share. Shares are up 1.66% at this moment of pre-market trading, coming up from its near-lows year to date. For more on JNJ’s earnings, click here.

These amount to just a sample of what we are about to see in the days and weeks ahead. Will Q3 bear out better than expected, or are we destined for an earnings recession? For a comprehensive view on the subject, check out this interview with Zacks Director of Research Sheraz Mian: Are We In an Earnings Recession?



JPMorgan Chase & Co. (NYSE:JPM

Johnson & Johnson (JNJ): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.